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Results of temperature-dependent magnetization measurements (Fig. 3D , red curve) show coupling between the electric and magnetic order parameters in the self-assembled nanostructure. This is manifested as a distinct drop in the magnetization of ϳ16 emu/cm 3 (ϳ5% of magnetization at a 100-Oe external field) around the ferroelectric Curie temperature (T c ϳ 390 K). At temperatures higher than T c , the CoFe 2 O 4 is compressed due to the lattice mismatch with BaTiO 3 . For T Ͻ T c , the tetragonal distortion in the BaTiO 3 lattice decreases this compression in the CoFe 2 O 4 . Because CoFe 2 O 4 has a negative magnetostriction, it results in a reduction of the moment, as observed in our experiments. The change of magnetization near T c can be estimated as ⌬M/M ϰ QP 2 Y(d/ dM)/M from a minimization of free energy (Eq. 4). However, quantitative estimation is difficult due to a lack of information about temperature dependence of 001 (M). For comparison, the temperature dependence of magnetization at 100 Oe (black curve in Fig. 3D ) for a CoFe 2 O 4 -BaTiO 3 multilayer sample with a layer thickness of ϳ30 nm shows negligible change around the ferroelectric Curie temperature. This can be understood as a consequence of the in-plane piezo-deformation in the multilayer structure being clamped by the substrate, thus precluding any deformation in the magnetic layer. This also proves that the coupling is dominated by elastic interactions in twophase nanostructures. The Caenorhabditis elegans vulva is an important paradigm for cell-cell interactions in animal development. The fates of six vulval precursor cells are patterned through the action of the epidermal growth factor receptor-mitogenactivated protein kinase (EGFR-MAPK) inductive signaling pathway, which specifies the 1°fate, and the LIN-12/Notch lateral signaling pathway, which specifies the 2°fate. Here, we provide evidence that the inductive signal is spatially graded and initially activates the EGFR-MAPK pathway in the prospective 2°c ells. Subsequently, this effect is counteracted by the expression of multiple new negative regulators of the EGFR-MAPK pathway, under direct transcriptional control of the LIN-12-mediated lateral signal.
The six vulval precursor cells (VPCs) are consecutively numbered P3.p to P8.p (Fig. 1A) . Each VPC has the potential to adopt one of three fates, termed 1°, 2°, or 3°. Descendants of the 1°and 2°cells constitute the vulva; the 3°c ell daughters join the major hypodermal syncytium. Vulval development [reviewed in (1) ] is initiated when LIN-3, an EGF-like signal produced by the gonad, activates the EGFR homolog LET-23 in the central VPC, P6.p. Activated LET-23, by means of a canonical Ras-MAPK cascade, causes P6.p to adopt the 1°fate and transcribe genes encoding the lateral signal (2) . The lateral signal activates the receptor LIN-12/Notch in the two neighboring VPCs, P5.p and P7.p, causing them to adopt the 2°fate. Without activation of either the inductive or lateral signaling pathways, P3.p, P4.p, and P8.p adopt the 3°fate, believed to be as a result of inhibitory influences from the hypodermal syncytium.
Genetic and cell-ablation experiments have led to different models of inductive signaling (1) . One model proposes that the inductive signal forms a morphogen gradient from the anchor cell, such that a high level of inductive signal causes the 1°fate, whereas a lower level helps specify the 2°fate (3). An alternative model proposes that VPC patterning is achieved by "sequential induction," such that the inductive signal activates LET-23 only in P6.p, leading to a lateral signal that then induces P5.p and P7.p to adopt the 2°1 †To whom correspondence should be addressed. Email: greenwald@cancercenter.columbia.edu fate (4, 5) . Here, we have reexamined the question of whether there is a graded inductive signal and how it may contribute to the specification of the 2°fate.
To determine whether there is a graded inductive signal, we asked whether we could detect graded expression of a reporter that responds to the EGFR-MAPK pathway in the VPCs. Expression of the gene egl-17 was previously shown to be promoted by the EGFR-mediated inductive signal but not by the LIN-12-mediated lateral signal using a green fluorescent protein (GFP) reporter (6). We created a similar reporter gene, but instead of using GFP, we used cyan fluorescent protein-LacZ (CFP-LacZ), which is much brighter. The arIs92 [egl-17p::cfp-lacZ] reporter is initially expressed in a graded fashion, highest in P6.p and lower in P5.p and P7.p. The expression in P5.p and P7.p disappears, and CFP-LacZ remains detectable only in P6.p and its descendants (Fig. 1B) . CFPLacZ expression depends on inductive signaling, because in the background of a mutation that reduces the inductive signal, lin-3(e1417) (7), neither the initial nor the subsequent CFP-LacZ expression is seen (8) . The initial expression of egl-17p::cfp-lacZ suggests that the inductive signal is spatially graded and has a detectable impact on VPCs other than P6.p; the loss of expression in the presumptive 2°cells suggests that activation of the EGFR-MAPK pathway is counteracted by the LIN-12-mediated lateral signal.
To determine how the EGFR-mediated inductive signal is countered by the LIN-12-mediated lateral signal, we used a biocomputational approach (9) to identify 10 candidate lateral signal target (lst) genes (Fig. 2 and  fig. S1 ) that may be involved in negative regulation of the EGFR-MAPK pathway. Each candidate lst gene contains a cluster of binding sites for LAG-1 (10) in conjunction with two new sequence motifs (motifs 1 and 2) (9). LAG-1 is a DNA binding protein that forms a complex with the LIN-12 intracellular domain to activate transcription of target genes, so genes with clustered LAG-1 binding sites (LBSs) are potential direct targets of LIN-12 [see also (11) ]. We examined the effect of depleting the activity of the 10 candidate genes in two functional assays and found that ark-1 (12) and five additional candidates (dpy-23, lst-1, lst-2, lst-3, and lst-4) behave as negative regulators of EGFR-MAPK activity. Four of these new candidates have mammalian orthologs (13) . The MAPK phosphatase lip-1, reported to be a LIN-12 target gene in the VPCs while our work was in progress (14) , also is identified in searches for genes that contain LBS clusters in conjunction with motifs 1 and 2 (9) .
We used an established assay that previously demonstrated ark-1 as a negative regulator of EGFR-MAPK (12) . This assay detects elevated EGFR-MAPK activity in presumptive 3°cells as ectopic vulval induction in a gap-1(0) genetic background. In this assay, depletion of lst-2, lst-3, lst-4, or dpy-23, as well as ark-1, caused ectopic vulval induction, suggesting that they function as negative regulators of the EGFR-MAPK pathway (Fig. 2A) .
To assay negative regulation of EGFR-MAPK activity directly in prospective 2°cells without the potentially confounding effect of a cell-fate transformation, we developed a new functional assay (Fig. 2B ) based on the observation that egl-17 expression normally becomes restricted to the daughters of P6.p (Fig. 1B) . We reasoned that, if the loss of egl-17p::cfp-lacZ expression in presumptive 2°cells reflects negative regulation of the EGFR-MAPK pathway by lst gene activity, then depletion of lst gene activity would cause egl-17p::cfp-lacZ expression to persist. We tested this assumption by depleting the activity of known negative regulators such as gap-1(0) and observed persistent expression of CFP in the daughters of VPCs other than P6.p without perturbation of vulval development, i.e., without a cell-fate transformation. Using this assay, we found that reducing the activity of ark-1, dpy-23, lst-1, lst-2, lst-3, and lst-4 results in ectopic egl-17 reporter expression in P5.p and P7.p daughters, indicating that these genes negatively regulate EGFR-MAPK signaling in the presumptive 2°VPCs (Fig. 2B) . We note that the strongly positive results for lst-1 and lst-3, as compared with the gap-1(0) ectopic induction assay, suggest that persistent egl-17p::cfp-lacZ expression is a very sensitive assay.
Transcriptional reporters (15) for the new negative regulators display strong and dynamic expression in the VPCs consistent with 
unc-101(-), sy108; lip-1(0), zh15; ark-1(-), sy247] (30).
Note that we also identified ark-1 as a candidate lst gene.
transcriptional response to the lateral signal. There are two general patterns. For genes that display Pattern A (dpy-23, lst-3), expression is very faint in the VPCs prior to the mid-L3 stage, but then becomes strong in P5.p and P7.p, and persists in their daughters (Fig.  3A) . This pattern suggests that expression of these genes is activated upon lateral signaling, an inference that was confirmed by mutation of the LBS cluster for dpy-23 (Fig. 3B) .
For genes that display Pattern B (lst-1, lst-2, and lst-4), uniform high expression is initially evident in all six VPCs, but at the time of inductive signaling, expression forms a gradient that is the inverse of the egl-17 reporter expression pattern in response to inductive signal: Expression of Pattern B genes is low in P6.p, intermediate in P5.p and P7.p, and undiminished in P3.p, P4.p, and P8.p. Later, expression becomes strong again in P5.p and P7.p and their daughters, but remains low in P6.p and its daughters (Fig.  3A) . Mutation of the LBS cluster in lst-1 does not affect the initial inverse gradient of expression but abrogates up-regulation in P5.p and P7.p (Fig. 3B) . A simple model to explain Pattern B is that the graded inductive signal initially leads to graded transcriptional repression of these lst genes, perhaps mediated by lin-1 (16) , but that lateral signaling subsequently restores full expression in P5.p and P7.p
In sum, we have provided evidence that a spatially graded inductive signal has a detectable impact on VPCs other than P6.p. We have also shown that, in addition to the MAPK phosphatase lip-1 (14) , LIN-12 activates the expression of many different negative regulators of the EGFR-MAPK pathway in P5.p and P7.p, which seem likely to inhibit the activity of this pathway at different steps (13) . The study of lip-1 raised the possibility that negative regulation of EGFR-MAPK activity in presumptive 2°cells plays a role in their specification, but because lip-1(0) does not cause defects in an otherwise wild-type background (14) , the contribution of this negative regulation to the final patterning remained an open question. However, our finding that there are multiple LIN-12 target genes that perform this function implies a high degree of redundancy in this regulatory process and suggests that the effect of the spatial gradient of inductive signal must be countered for proper VPC patterning. These considerations suggest the revised model for VPC specification shown in Fig. 4 .
It may be important to squelch EGFR-MAPK activity in the prospective 2°cells, because expression of 1°characteristics may have adverse effects. In P6.p, the presumptive 1°cell, the inductive signal leads to transcriptional activation of genes encoding the lateral signal (2) . Inappropriate expression of ligands for LIN-12 in P5.p and P7.p might activate LIN-12 in the prospective 3°c ells, confounding their correct cell-fate choice, or inhibit the ability of LIN-12 to be activated in P5.p and P7.p by ligand produced by P6.p (17, 18) . In addition, in P6.p, activation of the EGFR-MAPK pathway causes endocytosis-mediated down-regulation of LIN-12 (19) ; if inappropriate activation of the EGFR-MAPK pathway in P5.p and P7.p were to reduce the level of surface LIN-12, it would be less available to be activated by the lateral signal.
Because the principles and pathways elucidated by studying C. elegans vulval development have been generally applicable to other organisms, we speculate that this highly redundant mode by which LIN-12/Notch antagonizes EGFR-MAPK also operates in other situations. For example, there is evidence that Notch can function as either an oncogene or as a tumor suppressor, depending on the cellular context (20) . Perhaps where Notch has been observed to act as a tumor suppressor, it may be instructive to examine the expression of orthologs of the lst genes and other negative regulators of the EGFR-MAPK pathway. Neil Brockdorff 1 *
It is generally accepted that paternally imprinted X inactivation occurs exclusively in extraembryonic lineages of mouse embryos, whereas cells of the embryo proper, derived from the inner cell mass (ICM), undergo only random X inactivation. Here we show that imprinted X inactivation, in fact, occurs in all cells of early embryos and that the paternal X is then selectively reactivated in cells allocated to the ICM. This contrasts with more differentiated cell types where X inactivation is highly stable and generally irreversible. Our observations illustrate that an important component of genome plasticity in early development is the capacity to reverse heritable gene silencing decisions.
X inactivation is the developmentally regulated silencing of one of the two X chromosomes in female mammals, providing the mechanism for dosage compensation of Xlinked genes relative to XY males. In mouse embryos, there is imprinted X inactivation of the paternal X chromosome (Xp) in the extraembryonic trophectoderm (TE) and primitive endoderm (PE). In all other cells, X inactivation is random. Establishment of these patterns has been thought to occur in a lineage-specific manner, with imprinted X inactivation initiated only in TE and PE cells as they differentiate at the blastocyst stage. In contrast, ICM cells, which give rise to the embryo proper, have been thought to retain both X chromosomes in the active state until they differentiate and undergo random X inactivation during early postimplantation development (1-5). Paradoxically, Xist RNA, the cis-acting signal that initiates X inactivation, is expressed from Xp as early as the two-cell stage (6, 7) . This has been rationalized by supposing that cells of the early embryo cannot respond to Xist RNA (6) . In a recent study, we have shown that recruitment of the Eed-Ezh2 PolycombGroup (PcG) complex to the inactive X (Xi), is required to establish trimethylation of histone H3 lysine-27 (H3-K27) in postimplantation embryos (8) . In the course of analyzing localization of Eed-Ezh2 on Xi in preimplantation embryos, we found that PcG localization occurs in all cells of early-and midstage XX blastocysts, including those corresponding morphologically to the ICM (Fig. 1A) . In contrast, localization to Xi was no longer detectable in the ICM region of late-stage blastocysts, despite high levels of the Eed-Ezh2 proteins in the nuclei (Fig.  1B ). Scoring data demonstrate that only early-stage blastocysts have Eed-Ezh2 foci in 100% of cells (Fig. 1C) . In dual staining experiments, Ezh2 was seen to colocalize with Eed at all stages analyzed and EedEzh2 foci colocalized with Xist RNA domains ( fig. S1 , A to C).
Eed-Ezh2 localization to Xi in the ICM was confirmed using dual staining for Eed and the recently described homeodomain protein Nanog, expressed specifically in ICM cells (9, 10) . Eed foci were detectable in all Nanog-positive cells in early-and mid-stage blastocysts (Fig. 1, D and E) but were progressively lost at later stages (Fig. 1F) . Interestingly, loss of Eed foci in the ICM region of maturing blastocysts occurs specifically in Nanog-positive cells, representing precursors of the embryo proper, but does not occur in Nanog-negative cells, which represent the primitive endoderm lineage.
Our observations led us to consider that imprinted X inactivation may occur in all cells of early blastocysts and may then be selectively reversed in the ICM, establishing the ground state for subsequent random X inactivation. To determine whether early ICM cells exhibit other markers of X inactivation, we carried out dual labeling for Eed and specific modifications 
